Alleghany Corporation’s Zimmer Biomet ZBH Stock Holding History

Alleghany Corporation’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-581,476	Closed	-$82.6M	–	35
2021 Q3	$82.6M	Hold	581,476	–	–	2.55%	21
2021 Q2	$90.8M	Hold	581,476	–	–	2.7%	20
2021 Q1	$90.4M	Sell	581,476 -8,915	-2%	-$1.38M	2.89%	19
2020 Q4	$88.3M	Buy	590,391 +34,881	+6%	+$4.93M	3.52%	15
2020 Q3	$73.4M	Buy	555,510 +299,514	+117%	+$39.1M	3.73%	12
2020 Q2	$29.7M	Buy	255,996 +49,589	+24%	+$5.71M	2.38%	17
2020 Q1	$20.3M	Buy	206,407 +27,187	+15%	+$3.56M	1.36%	19
2019 Q4	$26M	Buy	+179,220	New	+$24.7M	1.21%	20

Other funds holding ZBH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Alleghany Corporation's ZBH Position: Q4 2021 in Review

Alleghany Corporation sold out of Zimmer Biomet (ZBH) in Q4 2021, closing a stake of 581,476 shares — an estimated $82.6M sold.

Alleghany Corporation first reported a position in ZBH in Q4 2019 and held it in 8 quarters. The position peaked at $90.8M in Q2 2021. 998 funds tracked by Wall St. Rank hold ZBH as of Q4 2021.

Alleghany Corporation reported no remaining Zimmer Biomet position as of Q4 2021 after selling out during the quarter.
Alleghany Corporation sold 581,476 Zimmer Biomet shares in Q4 2021, an estimated $82.6M.
Alleghany Corporation first reported a position in Zimmer Biomet in Q4 2019 and held it in 8 quarters.
Alleghany Corporation's Zimmer Biomet position peaked at $90.8M in Q2 2021.
998 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2021.

Based on Alleghany Corporation's 13F filing for Q4 2021, filed 8 Feb 2022.